Navidea Biopharmaceuticals, Inc. (NYSEAM:NAVB) announced intent to sell Cardinal Milestone Payment for $8 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0392 USD | -2.00% | +12.00% | -28.99% |
1st Jan change | Capi. | |
---|---|---|
-28.99% | 4M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- NAVB Stock
- News Navidea Biopharmaceuticals, Inc.
- Navidea Biopharmaceuticals Intends to Sell Cardinal Milestone Payment